Correlation Between CAVA Group, and Cumberland Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CAVA Group, and Cumberland Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CAVA Group, and Cumberland Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CAVA Group, and Cumberland Pharmaceuticals, you can compare the effects of market volatilities on CAVA Group, and Cumberland Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CAVA Group, with a short position of Cumberland Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CAVA Group, and Cumberland Pharmaceuticals.

Diversification Opportunities for CAVA Group, and Cumberland Pharmaceuticals

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between CAVA and Cumberland is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding CAVA Group, and Cumberland Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cumberland Pharmaceuticals and CAVA Group, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CAVA Group, are associated (or correlated) with Cumberland Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cumberland Pharmaceuticals has no effect on the direction of CAVA Group, i.e., CAVA Group, and Cumberland Pharmaceuticals go up and down completely randomly.

Pair Corralation between CAVA Group, and Cumberland Pharmaceuticals

Given the investment horizon of 90 days CAVA Group, is expected to generate 13.12 times more return on investment than Cumberland Pharmaceuticals. However, CAVA Group, is 13.12 times more volatile than Cumberland Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Cumberland Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  0.00  in CAVA Group, on August 31, 2024 and sell it today you would earn a total of  14,090  from holding CAVA Group, or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.93%
ValuesDaily Returns

CAVA Group,  vs.  Cumberland Pharmaceuticals

 Performance 
       Timeline  
CAVA Group, 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CAVA Group, are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat sluggish basic indicators, CAVA Group, sustained solid returns over the last few months and may actually be approaching a breakup point.
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cumberland Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward indicators, Cumberland Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

CAVA Group, and Cumberland Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CAVA Group, and Cumberland Pharmaceuticals

The main advantage of trading using opposite CAVA Group, and Cumberland Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CAVA Group, position performs unexpectedly, Cumberland Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cumberland Pharmaceuticals will offset losses from the drop in Cumberland Pharmaceuticals' long position.
The idea behind CAVA Group, and Cumberland Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format